| 1 | tucson 5207484400 about us professional | | | | | | | 1 | 0.33% |
| 2 | rct develops and invests | | | | | | | 1 | 0.33% |
| 3 | technologies that have the | | | | | | | 1 | 0.33% |
| 4 | that have the potential | | | | | | | 1 | 0.33% |
| 5 | have the potential to | | | | | | | 1 | 0.33% |
| 6 | the potential to become | | | | | | | 1 | 0.33% |
| 7 | significant biomedical products with | | | | | | | 1 | 0.33% |
| 8 | biomedical products with a | | | | | | | 1 | 0.33% |
| 9 | products with a definite | | | | | | | 1 | 0.33% |
| 10 | with a definite competitive | | | | | | | 1 | 0.33% |
| 11 | edge learn more › technologies | | | | | | | 1 | 0.33% |
| 12 | more › technologies rct | | | | | | | 1 | 0.33% |
| 13 | › technologies rct develops | | | | | | | 1 | 0.33% |
| 14 | technologies rct develops and | | | | | | | 1 | 0.33% |
| 15 | develops and invests in | | | | | | | 1 | 0.33% |
| 16 | companies with technologies that | | | | | | | 1 | 0.33% |
| 17 | technologies that enhance and | | | | | | | 1 | 0.33% |
| 18 | that enhance and enable | | | | | | | 1 | 0.33% |
| 19 | enhance and enable the | | | | | | | 1 | 0.33% |
| 20 | and enable the discovery | | | | | | | 1 | 0.33% |
| 21 | enable the discovery and | | | | | | | 1 | 0.33% |
| 22 | the discovery and manufacture | | | | | | | 1 | 0.33% |
| 23 | discovery and manufacture of | | | | | | | 1 | 0.33% |
| 24 | therapeutics and diagnostics many | | | | | | | 1 | 0.33% |
| 25 | and diagnostics many of | | | | | | | 1 | 0.33% |
| 26 | diagnostics many of these | | | | | | | 1 | 0.33% |
| 27 | many of these life | | | | | | | 1 | 0.33% |
| 28 | of these life science | | | | | | | 1 | 0.33% |
| 29 | these life science tools | | | | | | | 1 | 0.33% |
| 30 | with technologies that have | | | | | | | 1 | 0.33% |
| 31 | to startup or earlystage | | | | | | | 1 | 0.33% |
| 32 | available from rct through | | | | | | | 1 | 0.33% |
| 33 | offering biomedical innovators the | | | | | | | 1 | 0.33% |
| 34 | advamed 2015 licensing breakthrough | | | | | | | 1 | 0.33% |
| 35 | 2015 licensing breakthrough technologies | | | | | | | 1 | 0.33% |
| 36 | licensing breakthrough technologies in | | | | | | | 1 | 0.33% |
| 37 | breakthrough technologies in the | | | | | | | 1 | 0.33% |
| 38 | technologies in the life | | | | | | | 1 | 0.33% |
| 39 | sciences rct licenses new | | | | | | | 1 | 0.33% |
| 40 | rct licenses new promising | | | | | | | 1 | 0.33% |